《大行報告》摩通上調創科(00669.HK)目標價151元 評級「增持」
摩根大通發表報告指,即使市場對創科實業(00669.HK)去年的業績已有良好預測,但其表現仍明顯優於預期。受穩固的創新無線產品線、追求更高生產力,及消費者喜好方便使用的工具等支持,估計集團今年會繼續保持增長勢頭。
該行上調創科股份目標價,由144元升至151元,評級維持「增持」,並調升集團今年盈利預測5%。摩通相信,集團跑贏同業的能見度清晰,且繼續有強勁的毛利率。此外,其國際擴張、製造擴張及供應鏈重組的戰略,可令集團有良好定位,以捕捉未來增長等。評級「增持」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.